StockNews.com Begins Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

Equities research analysts at StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a note issued to investors on Sunday. The firm set a “sell” rating on the stock.

Ampio Pharmaceuticals Stock Performance

AMPE opened at $0.00 on Friday. Ampio Pharmaceuticals has a 52-week low of $0.00 and a 52-week high of $1.74. The firm has a market cap of $2,383.50, a PE ratio of 0.00 and a beta of 3.78.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.